The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for rare lymphomas such as:
- Mantle cell lymphoma
- Burkitt's lymphoma
- MALToma (Marginal zone) lymphoma
- CNS (brain) lymphoma
If you would like to know how to access our trials please click here
Trial name |
Description |
Click for more information (external page) |
GEN3013 |
Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non Hodgkin lymphoma
|
|
ENRICH |
A phase 2/3 trial looking at treatment options for people over 60 with mantle cell lymphoma who are unable to have a stem cell transplant
|
|
JCAR017 |
Phase 2 study determining efficacy and safety of JCAR017.
|
|
RIVA |
A phase 2 trial testing the combination of rituximab and varlilumab.
|
|
MAGNOLIA |
Phase 2 trial to test the safety and effectiveness of zanubrutinib also known as BGB-3111 in patients with marginal zone (MALT) lymphoma.
|
|
GO29781 |
A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab. Suitable for patients with lymphoma which has come back after previous treatment
|
*Please note, we update this page fortnightly
With special thanks to the following: